摘要
Synthetic biology(SynBio)is an emerging field of study with great potential in designing,engineering,and constructing new microbial synthetic cells that do not pre-exist in nature or re-engineering existing cells to accomplish industrial purposes.Systems biology seeks to understand biology at multiple dimensions,beginning with the molecular and cellular level and progressing to the tissues and organismal level and characterizes cells as complex information-processing systems.SynBio,on the other hand,toggles further and strives to develop and create its systems from scratch.SynBio is now applied in the development of novel therapeutic drugs for the prevention of human diseases,scale up industrial processes,and accomplish previously unfeasible industrial outcomes.This is made possible through significant breakthroughs in DNA sequencing and synthesis technology,as well as insights gained from synthetic chemistry and systems biology.SynBio technologies have allowed for the introduction of improved and synthetic metabolic functionalities in microorganisms to enable the synthesis of a range of pharmacologically-relevant compounds for pharmaceutical exploration.SynBio applications range from finding new ways to making industrial chemical synthesis processes more sustainable as well as the microbial synthesis of improved therapeutic modalities.Hence,this study underpins several innovations,auspicious potentials,and future directions afforded by SynBio that proposes improved industrial microbial synthesis for pharmaceutical exploration.
